SSC.BK | Sermsuk Public Company Limited Annual & Quarterly

Annual Balance Sheets

(In THB)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	14.08 Billion	13.67 Billion	12.78 Billion	12.49 Billion	12.4 Billion	11.65 Billion
Total Current Assets	4.03 Billion	3.5 Billion	2.92 Billion	2.72 Billion	2.36 Billion	2.2 Billion
Cash And Short Term Investments	2.35 Billion	1.97 Billion	1.71 Billion	1.4 Billion	872.79 Million	506.2 Million
Cash and Cash Equivalents	2.29 Billion	1.32 Billion	1.06 Billion	1.4 Billion	872.79 Million	506.2 Million
Short Term Investments	56.84 Million	654.29 Million	651.84 Million	-	-	-
Net Receivables	890.54 Million	842.65 Million	554.14 Million	700.05 Million	754.78 Million	1.01 Billion
Inventory	754.38 Million	663.27 Million	617.44 Million	587.08 Million	676.48 Million	604.58 Million
Other Current Assets	32.45 Million	24.75 Million	33.49 Million	29.37 Million	42.11 Million	21.14 Million
Total Non-Current Assets	10.04 Billion	10.16 Billion	9.85 Billion	9.77 Billion	10.03 Billion	9.45 Billion
Net PPE	8.24 Billion	8.46 Billion	8.26 Billion	8.31 Billion	8.74 Billion	8.26 Billion
Good Will And Intangible Assets	35.39 Million	41.49 Million	46.25 Million	16.31 Million	18.41 Million	19.75 Million
Good Will	-	-	-	-	-	-
Intangible Assets	35.39 Million	41.49 Million	46.25 Million	16.31 Million	18.41 Million	19.75 Million
Long-Term Investments	1.26 Billion	1.15 Billion	1.05 Billion	936.7 Million	770.88 Million	666.12 Million
Tax Assets	21.34 Thousand	21.34 Thousand	21.34 Thousand	96.96 Thousand	95.55 Thousand	3.51 Million
Other Non Current Assets	503.86 Million	501.98 Million	490.8 Million	514.89 Million	498.56 Million	493.27 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	4.52 Billion	4.35 Billion	3.78 Billion	3.6 Billion	3.66 Billion	3.11 Billion
Total Current Liabilities	2.42 Billion	2.29 Billion	1.92 Billion	1.99 Billion	2.01 Billion	2.13 Billion
Account Payables	800.86 Million	801.98 Million	489.09 Million	576.4 Million	640.77 Million	764.14 Million
Tax Payables	691.04 Thousand	49.08 Thousand	9597.00	-	78.49 Million	81.42 Million
Short Term Debt	116.85 Million	99 Million	98.15 Million	934.15 Million	896.32 Million	877.26 Million
Deferred Revenue	462.74 Million	457.68 Million	455.63 Million	453.57 Million	442.71 Million	444.42 Million
Other Current Liabilities	1.04 Billion	935.04 Million	878.56 Million	31.3 Million	37.15 Million	48.47 Million
Total Non Current Liabilities	2.09 Billion	2.06 Billion	1.85 Billion	1.6 Billion	1.64 Billion	984.41 Million
Long-Term Debt	297.45 Million	300.93 Million	258.23 Million	-	-	-
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	892.59 Million	920.92 Million	1.01 Billion	1.13 Billion	1.18 Billion	933.44 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	9.55 Billion	9.31 Billion	9 Billion	8.89 Billion	8.73 Billion	8.54 Billion
Stock Holders Equity	9.55 Billion	9.31 Billion	9 Billion	8.89 Billion	8.73 Billion	8.54 Billion
Common Stock	265.9 Million	265.9 Million	265.9 Million	265.9 Million	265.9 Million	265.9 Million
Retained Earnings	1.55 Billion	1.31 Billion	1.33 Billion	1.28 Billion	1.11 Billion	1.62 Billion
Accumulated other comprehensive income	2.31 Billion	2.31 Billion	2.31 Billion	2.31 Billion	2.31 Billion	2.31 Billion
Common Stock Equity	9.55 Billion	9.31 Billion	9 Billion	8.89 Billion	8.73 Billion	8.54 Billion
Capital Lease Obligation	414.3 Million	399.93 Million	356.38 Million	-	-	-
Total Investments	1.32 Billion	1.81 Billion	1.71 Billion	936.7 Million	770.88 Million	666.12 Million
Total Debt	414.3 Million	399.93 Million	356.38 Million	-	-	-
Net Debt	-1.88 Billion	-921.1 Million	-711.04 Million	-1.4 Billion	-872.79 Million	-506.2 Million

Breakdown	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3
Total Assets	14.39 Billion	14.08 Billion	14.04 Billion	14.08 Billion	14.08 Billion	14.04 Billion
Total Current Assets	4.41 Billion	4.15 Billion	4.08 Billion	4.03 Billion	4.03 Billion	4.03 Billion
Cash And Short Term Investments	2.64 Billion	2.29 Billion	2.33 Billion	2.35 Billion	2.35 Billion	2.13 Billion
Cash and Cash Equivalents	2.58 Billion	2.23 Billion	2.27 Billion	2.29 Billion	2.29 Billion	2.07 Billion
Short Term Investments	57.74 Million	57.43 Million	57.12 Million	56.84 Million	56.84 Million	56.6 Million
Net Receivables	976.18 Million	1.05 Billion	944.98 Million	890.54 Million	890.54 Million	1.05 Billion
Inventory	776.91 Million	782.2 Million	768.21 Million	754.38 Million	754.38 Million	798.94 Million
Other Current Assets	15.53 Million	16.85 Million	38.06 Million	32.45 Million	32.45 Million	42.68 Million
Total Non-Current Assets	9.98 Billion	9.93 Billion	9.95 Billion	10.04 Billion	10.04 Billion	10.01 Billion
Net PPE	8.12 Billion	8.12 Billion	8.14 Billion	8.24 Billion	8.24 Billion	8.24 Billion
Good Will And Intangible Assets	30.81 Million	32.32 Million	33.84 Million	35.39 Million	35.39 Million	36.8 Million
Good Will	-	-	-	-	-	-
Intangible Assets	30.81 Million	32.32 Million	33.84 Million	35.39 Million	35.39 Million	36.8 Million
Long-Term Investments	1.7 Billion	1.65 Billion	1.29 Billion	1.26 Billion	1.26 Billion	1.25 Billion
Tax Assets	21 Thousand	21 Thousand	21 Thousand	21.34 Thousand	21.34 Thousand	1.92 Million
Other Non Current Assets	125.72 Million	124.34 Million	483.19 Million	503.86 Million	503.86 Million	473.88 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	4.65 Billion	4.48 Billion	4.43 Billion	4.52 Billion	4.52 Billion	4.65 Billion
Total Current Liabilities	2.63 Billion	2.45 Billion	2.33 Billion	2.42 Billion	2.42 Billion	2.63 Billion
Account Payables	884.99 Million	845.71 Million	841.7 Million	800.86 Million	800.86 Million	930.64 Million
Tax Payables	21.22 Million	4.37 Million	2.83 Million	691.04 Thousand	691.04 Thousand	662 Thousand
Short Term Debt	90.27 Million	92.26 Million	93.83 Million	116.85 Million	116.85 Million	103.87 Million
Deferred Revenue	465.48 Million	464.8 Million	463.19 Million	462.74 Million	462.74 Million	462.18 Million
Other Current Liabilities	1.19 Billion	1.05 Billion	932.78 Million	1.04 Billion	1.04 Billion	1.14 Billion
Total Non Current Liabilities	2.02 Billion	2.03 Billion	2.09 Billion	2.09 Billion	2.09 Billion	2.01 Billion
Long-Term Debt	263.89 Million	282.18 Million	300.46 Million	297.45 Million	297.45 Million	272.67 Million
Deferred Revenue Non Current	-	-1.00	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	843.42 Million	835.84 Million	891.18 Million	892.59 Million	892.59 Million	887.17 Million
Other Liabilities	-	1.00	-	-	-	-
Total Equity	9.74 Billion	9.59 Billion	9.61 Billion	9.55 Billion	9.55 Billion	9.38 Billion
Stock Holders Equity	9.74 Billion	9.59 Billion	9.61 Billion	9.55 Billion	9.55 Billion	9.38 Billion
Common Stock	265.89 Million	265.89 Million	265.9 Million	265.9 Million	265.9 Million	265.9 Million
Retained Earnings	1.7 Billion	1.56 Billion	1.61 Billion	1.55 Billion	1.55 Billion	1.38 Billion
Accumulated other comprehensive income	2.41 Billion	2.41 Billion	2.31 Billion	2.31 Billion	2.31 Billion	2.31 Billion
Common Stock Equity	9.74 Billion	9.59 Billion	9.61 Billion	9.55 Billion	9.55 Billion	9.38 Billion
Capital Lease Obligation	263.89 Million	282.18 Million	394.3 Million	414.3 Million	414.3 Million	376.55 Million
Total Investments	1.75 Billion	1.7 Billion	1.35 Billion	1.32 Billion	1.32 Billion	1.31 Billion
Total Debt	354.16 Million	374.45 Million	394.3 Million	414.3 Million	414.3 Million	376.55 Million
Net Debt	-2.23 Billion	-1.86 Billion	-1.88 Billion	-1.88 Billion	-1.88 Billion	-1.7 Billion

Balance Sheet Charts

RSD Finance Limited

RSDFIN

Full Analysis

Annual Balance Sheets
SideChannel, Inc.

SDCH

Full Analysis

Annual Balance Sheets
Elspec Engineering Ltd

ELSPC

Full Analysis

Annual Balance Sheets
Descente Ltd.

8114

Full Analysis

Annual Balance Sheets
Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204

Full Analysis

Annual Balance Sheets
Nickel Asia Corporation

NCKAF

Full Analysis

Annual Balance Sheets

Global Stocks Search

Sermsuk Public Company Limited (SSC.BK)

Annual Balance Sheets

Balance Sheet Charts

RSD Finance Limited

SideChannel, Inc.

Elspec Engineering Ltd

Descente Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Nickel Asia Corporation